Davita INC Form 4 insider transactions

Director Gregory J. Moore reports acquiring 363 shares and disposing of 5,109 shares of DaVita Inc. common stock on May 15, 2024.

Director John M Nehra reports acquiring 363 shares of DaVita Inc. common stock and disposing of the same amount on May 15, 2024.

Director Jason M. Hollar reported acquiring 363 shares of DaVita Inc. common stock on May 15, 2024.

Director Barbara J. Desoer reports a transaction involving DaVita Inc. common stock.

Director Charles Berg reports acquisition and disposal of DaVita Inc. common stock.

Director Phyllis R. Yale reported acquiring 363 shares of DaVita Inc. common stock and disposing of 15,359 shares on May 15, 2024.

Director Wendy Lee Schoppert reported acquiring 363 shares of DaVita Inc. common stock and disposing of 1,183 shares on May 15, 2024.

Director Barbara J. Desoer reported selling 5,030 shares of DaVita Inc. common stock at an average price of $138.81 on May 10, 2024.

Director John M Nehra reports acquiring 366 shares of DaVita Inc. common stock on March 15, 2024.

Director Wendy Lee Schoppert reports acquiring 366 shares of DaVita Inc. common stock on March 15, 2024.

Director Charles Berg reports acquisition and disposal of DaVita Inc. common stock, along with holdings in a family trust.

Director Adam H. Schechter reported acquiring 366 shares of DaVita Inc. common stock and disposing of 2,625 shares on March 15, 2024.

Director Phyllis R. Yale reported acquiring 366 shares of DaVita Inc. common stock and disposing of an unspecified amount on March 15, 2024.

Director Pamela M. Arway reported acquiring 366 shares of DaVita Inc. common stock on March 15, 2024.

Director Gregory J. Moore reported acquiring 366 shares of DaVita Inc. common stock and disposing of 4,746 shares on March 15, 2024.

Director Jason M. Hollar of DaVita Inc. reports acquiring 366 shares of common stock and disposing of 3,538 shares on March 15, 2024.

Director Barbara J. Desoer reports acquiring and disposing of DaVita Inc. common stock on March 15, 2024.

James O. Hearty, Chief Compliance Officer of DaVita Inc., reports the acquisition and disposal of common stock related to performance stock units and restricted stock units.

Kathleen Waters, Chief Legal & Public Affairs Officer at DaVita Inc., reports acquisition and disposal of company stock related to performance stock unit vesting and tax obligations.

Christopher Michael Berry, Chief Accounting Officer of DaVita Inc., reported the acquisition of 3,659 restricted stock units on March 15, 2024.

Chief Operating Officer of DaVita Kidney Care, Michael Staffieri, reports acquisition and disposal of DaVita Inc. stock, including shares received from vested performance stock units and shares withheld for tax obligations.

CFO and Treasurer of DaVita Inc., Joel Ackerman, reports acquisition and disposal of company stock due to vesting of performance stock units and tax obligations.

Michael David Staffieri, Chief Operating Officer of DaVita Inc., exercised stock appreciation rights and disposed of shares to cover the base price and tax obligations.

Chief Operating Officer of DaVita Inc., Michael Staffieri, exercised stock appreciation rights and sold shares to cover the exercise price and tax obligations.

Joel Ackerman, CFO and Treasurer of DaVita Inc., exercised stock appreciation rights and sold shares to cover the exercise price and tax obligations on March 6, 2024.

DaVita Inc.'s CEO, Javier Rodriguez, exercised stock appreciation rights, acquiring and disposing of shares to cover the base price and tax obligations.

DaVita Inc. CEO Javier Rodriguez reports the acquisition and disposal of company stock and derivative securities, including the exercise of stock appreciation rights.